NeOnc Technologies Holdings is trading at $3.05, 10.38% down, with the October 1 decline’s catalyst unclear.

  • The price compares with the September 30 close of $3.40.
  • A report about adding Dr. Alexandra M. Miller to the Scientific Advisory Board does not establish a cause.
  • U.S. Treasury yields reached multi-year highs as broader markets faced pressure, but major indexes were mixed; available evidence does not show macro sentiment specifically drove the stock’s drop.